News

PSMA-targeted agent 225Ac-J591 shows promising safety and efficacy in mCRPC

View more

Nov 17, 2023

AdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of 212Pb-ADVC001 in Metastatic Prostate Cancer

View more

Nov 17, 2023

King Faisal Specialist Hospital and Research Centre Seeks to Achieve Self-Sufficiency in Radiopharmaceuticals in the Kingdom

View more

Nov 10, 2023

Clarity and PSI kick off SAR-bisPSMA Phase III

View more

Nov 10, 2023

NORTHSTAR MEDICAL RADIOISOTOPES STATEMENT ON CURRENT DISRUPTIONS IN THE MOLYBDENUM-99 (MO-99) SUPPLY CHAIN

View more

Nov 10, 2023

New Radiopharmaceutical Shows Antitumor Activity in Patients with Advanced Prostate Cancer

View more

Nov 10, 2023